Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dexbrompheniramine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 known ✓ | P35367 | 5/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 5/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 5/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 5/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 4/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 4/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 1.00 |
| ▸ | HTR2A | P28223 | 4/20 | 1.00 |
| ▸ | SCN1A | P35498 | 3/20 | 1.00 |
| ▸ | SCN2A | Q99250 | 3/20 | 1.00 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | DRD1 | P21728 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 2/20 | 1.00 |
| ▸ | THPO | P40225 | 2/20 | 1.00 |
| ▸ | HTR2C | P28335 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dexbrompheniramine SCHEMBL15516617 | 1.00 | CHRM2 (1.00) | CHRM2SLC6A2SLC6A4HRH1CHRM1 | |
| Brompheniramine SCHEMBL1604455 | 1.00 | CHRM2 (1.00) | CHRM2SLC6A2SLC6A4HRH1CHRM1 | |
| Brompheniramine SCHEMBL15516706 | 1.00 | CHRM2 (1.00) | CHRM2SLC6A2SLC6A4HRH1CHRM1 | |
| Brompheniramine SCHEMBL30182709 | 1.00 | CHRM2 (1.00) | CHRM2SLC6A2SLC6A4HRH1CHRM1 | |
| Brompheniramine SCHEMBL4814 | 1.00 | CHRM2 (1.00) | CHRM2SLC6A2SLC6A4HRH1CHRM1 | |
| Brompheniramine SCHEMBL4314531 | 1.00 | CHRM2 (1.00) | CHRM2SLC6A2SLC6A4HRH1CHRM1 | |
| Brompheniramine SCHEMBL6859988 | 0.99 | CHRM2 (0.97) | CHRM2SLC6A2SLC6A4HRH1CHRM1 | |
| Dexbrompheniramine SCHEMBL28086608 | 0.99 | CHRM2 (0.97) | CHRM2SLC6A2SLC6A4HRH1CHRM1 | |
| Dexbrompheniramine SCHEMBL3744666 | 0.94 | CHRM2 (0.88) | CHRM2SLC6A2SLC6A4HRH1CHRM1 | |
| Brompheniramine SCHEMBL1901052 | 0.94 | CHRM2 (0.88) | CHRM2SLC6A2SLC6A4HRH1CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4148 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| EP-4731194-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP Technologies, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4691492-A2 | LIQUID COMPOSITIONS | Kenvue Brands LLC (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2025264260-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP TECHNOLOGIES, INC. (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250332088-A1 | SUSTAINED RELEASE COMPOSITIONS | RUBICON RES PRIVATE LIMITED (IN) | 2025-10-30 | — | — | US | claimed |
| EP-4630401-A2 | CARBONIC ANHYDRASE ENZYME INHIBITORS AND METHODS OF USE THEREOF | Rutgers, the State University of New Jersey (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4247331-B1 | ORODISPERSIBLE POWDER COMPOSITION COMPRISING AN ANTIHISTAMINE COMPOUND | BIOPHARMA SYNERGIES S L (ES) | 2025-10-08 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-20250177398-A1 | CARBONIC ANHYDRASE ENZYMES FOR REGULATING MAST CELL HEMATOPOIESIS AND TYPE 2 INFLAMMATION | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-06-05 | — | — | US | claimed |
| EP-0097523-B1 | EXTENDED ACTION CONTROLLED RELEASE COMPOSITIONS | Euroceltique S.A. (LU) | 1988-01-13 | — | — | EP | claimed |
| US-4657757-A | Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate | SCHERING CORPORATION (US) | 1987-04-14 | — | — | US | claimed |
| US-4619934-A | AND ANTIHISTAMINE, DECONGESTANT, ANTITUSSIVE OR EXPECTORANT | ANALGESIC ASSOCIATES (US) | 1986-10-28 | — | — | US | claimed |
| US-4601894-A | ANALGLE0ICS | SCHERING CORPORATION (US) | 1986-07-22 | — | — | US | claimed |
| EP-0180597-A1 | COUGH/COLD MIXTURES COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. | SUNSHINE ABRAHAM (US) | 1986-05-14 | — | — | EP | claimed |
| WO-1985004589-A1 | COUGH/COLD MIXTURES COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | SUNSHINE ABRAHAM | 1985-10-24 | — | — | WO | claimed |
| US-4443428-A | PARAFFIN WAXES, ALCOHOLS, FREE BASE AND SALT MIXTURES | EUROCELTIQUE, S.A. (LU) | 1984-04-17 | — | — | US | claimed |
| EP-0097523-A2 | Extended action controlled release compositions | Euroceltique S.A. (LU) | 1984-01-04 | — | — | EP | claimed |
| US-4104382-A | (((THIAZOLYL-, ISOTHIAZOLYL- OR PYRIDYLALKYL)THIO)ALKYL)GUANIDINE | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1978-08-01 | — | — | US | claimed |
| US-4000302-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-12-28 | — | — | US | claimed |